In Latin American First, Argentina To Produce Russia's Sputnik V Vaccine
Mohammad Ali (@ChaudhryMAli88) Published April 21, 2021 | 01:20 AM
Buenos Aires, (UrduPoint / Pakistan Point News - 21st Apr, 2021 ) :Argentina will be the first Latin American country to produce Russia's Sputnik V coronavirus vaccine, according to Russia's RDIF sovereign fund, which financed the development of the shot.
A deal to this end has been struck with Argentina's Richmond pharmaceutical company, the fund announced on Tuesday.
The vaccine technology has been transferred to Richmond and full-scale production should start in June, RDIF said in a statement.
"Sputnik V is approved in more than 10 countries of Latin and Central America and production in Argentina will help facilitate deliveries to other partners in the region," it quoted RDIF executive director Kirill Dmitriev as saying.
Richmond has already produced a first batch of 21,000 doses, which will be sent for quality control to Russia's Gamaleya research institute, which developed the vaccine.
It will start in June to produce a million doses per month for a year, by when a new plant should be in service that is meant to produce five million doses per month.
"It will be a great opportunity to advance in the fight against the pandemic not only in Argentina, but also in Latin America," said Argentina's President Alberto Fernandez.
Richmond has received a government credit of some 30 million pesos (about $300,000), and will receive another 13 million pesos in financial assistance, it said.
On December 23, Argentina became the first Latin American country to approve Sputnik V, receiving 300,000 doses the following day to begin its immunization campaign.
Argentina has to date received nearly eight million vaccine doses, including almost 4.8 million doses of Sputnik V.
Some 5.6 million Argentines have received at least one vaccine dose to date, and 800,000 have received two shots.
Russia registered Sputnik V last August ahead of large-scale clinical trials, prompting concern among experts over the fast-track process.
But later reviews have been largely positive, with the medical journal The Lancet publishing results showing it to be safe and more than 90 percent effective.
The Russian vaccine has been approved for use in 60 countries.
Related Topics
Recent Stories
PTI to stage nationwide protests against alleged electoral frauds
Senate continues discussion on Presidential address to Joint Sitting of Parliame ..
Masood Khan calls for Pak-US cooperation for regional peace
Interior Minister starts Margalla Trail Patrol for security
Currency Rate In Pakistan - Dollar, Euro, Pound, Riyal Rates On 26 April 2024
Today Gold Rate in Pakistan 26 April 2024
ICC Womens T20 World Cup Qualifier, Match 2: Ireland Women open with Comfortable ..
Robinson, bowlers help New Zealand go 2-1 up against Pakistan
Shahzeb Chachar to hold khuli kachehri on April 26
Heatwave amid Israel's aggression in Gaza brings new misery, disease risk
Tourism must change, mayor says as Venice launches entry fee
Court adjourns Judicial Complex attack case till May 17
More Stories From Miscellaneous
-
Modern Education Techniques: A pathway to achieve economic development
6 hours ago -
Kite Flying: From cultural festival to deadly sport
6 hours ago -
PDMA predicts gusty wind, rain with thunder, hails
3 days ago -
Iranian president Raisi given guard of honour at PM House
4 days ago -
Intellectuals, writers accolades Naseer Mirza on his literary contribution
5 days ago -
Bahawalpur Adabi Sangat hosts memorable mushaira
5 days ago
-
Cattle farming vital to alleviate poverty in rural areas
5 days ago -
Pakistan: A land of tourism, archeological wonders
5 days ago -
Transforming education sector: from job hunters to job creators
7 days ago -
Amjad Bobby remembered on 19th death anniversary for timeless contributions to music
11 days ago -
Legendary actor Nadeem’s 26 films released on Eid-ul-Fitr days in 50 years
12 days ago -
Besant Hall Cultural Centre to celebrate evening with Sanam Marvi on 26 April
12 days ago